Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients.

Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients. Acta Radiol. 2020 Feb 28;:284185120905066 Authors: Losnegård A, Reisæter LAR, Halvorsen OJ, Jurek J, Assmus J, Arnes JB, Honoré A, Monssen JA, Andersen E, Haldorsen IS, Lundervold A, Beisland C PMID: 32108505 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32108505?dopt=Abstract

Source: Acta Radiologica - February 27, 2020 Category: Radiology Authors: Losnegård A, Reisæter LAR, Halvorsen OJ, Jurek J, Assmus J, Arnes JB, Honoré A, Monssen JA, Andersen E, Haldorsen IS, Lundervold A, Beisland C Tags: Acta Radiol Source Type: research

More News: Cancer | Cancer & Oncology | Prostate Cancer | Radiology